Lantern Pharma Inc.
LTRN
$3.59
-$0.03-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.86% | -37.55% | -30.63% | -25.58% | -25.17% |
| Total Receivables | -88.72% | -- | -- | -- | 45.22% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.51% | -34.30% | -41.12% | -51.78% | 55.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -6.15% | -24.24% | -82.06% | -- |
| Total Current Assets | -41.75% | -36.91% | -30.86% | -28.45% | -26.19% |
|
|
|||||
| Total Current Assets | -41.75% | -36.91% | -30.86% | -28.45% | -26.19% |
| Net Property, Plant & Equipment | 2.50% | 4.97% | -26.49% | -23.09% | 193.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 41.70% | 41.70% | 23.55% | -21.52% | 44.69% |
| Total Assets | -41.41% | -36.59% | -30.80% | -28.42% | -25.82% |
|
|
|||||
| Total Accounts Payable | 156.36% | 62.42% | 42.58% | 35.88% | 1.05% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.29% | 17.44% | 0.55% | 48.83% | 227.03% |
| Total Finance Division Other Current Liabilities | 10.36% | 65.70% | 74.55% | 45.46% | -13.79% |
| Total Other Current Liabilities | 10.36% | 65.70% | 74.55% | 45.46% | -13.79% |
| Total Current Liabilities | 61.72% | 59.81% | 52.55% | 41.54% | -4.29% |
|
|
|||||
| Total Current Liabilities | 61.72% | 59.81% | 52.55% | 41.54% | -4.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.15% | -11.74% | -63.70% | -88.90% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 60.02% | 56.58% | 47.01% | 35.29% | -2.09% |
|
|
|||||
| Common Stock & APIC | 0.83% | 0.17% | 0.17% | 0.44% | 0.59% |
| Retained Earnings | -37.62% | -37.39% | -37.05% | -40.64% | -40.63% |
| Treasury Stock & Other | 243.26% | 81.77% | 97.48% | 100.63% | 71.06% |
| Total Common Equity | -48.21% | -41.43% | -35.91% | -31.97% | -27.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.21% | -41.43% | -35.91% | -31.97% | -27.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.21% | -41.43% | -35.91% | -31.97% | -27.00% |
|
|
|||||